ADC Therapeutics SA Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
ADC Therapeutics SA quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2023 to Q2 2024.
  • ADC Therapeutics SA Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2024 was $17M, a 11.3% decline year-over-year.
  • ADC Therapeutics SA annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $69.1M, a 7.81% decline from 2022.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17M -$2.17M -11.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $17.8M -$1.11M -5.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q2 2023 $19.2M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $19M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.